In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi
- PMID: 11230410
- PMCID: PMC87856
- DOI: 10.1128/JCM.39.3.954-958.2001
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi
Abstract
The NCCLS proposed standard M38-P describes standard parameters for testing the fungistatic antifungal activities (MICs) of established agents against filamentous fungi (molds); however, standard conditions are not available for testing their fungicidal activities (minimum fungicidal or lethal concentrations [MFCs]). This study evaluated the in vitro fungistatic and fungicidal activities of voriconazole, itraconazole, and amphotericin B against 260 common and emerging molds (174 Aspergillus sp. isolates [five species], 23 Fusarium sp. isolates [three species], 6 Paecilomyces lilacinus isolates, 6 Rhizopus arrhizus isolates, 23 Scedosporium sp. isolates, 23 dematiaceous fungi, and 5 Trichoderma longibrachiatum isolates). MICs were determined by following the NCCLS M38-P broth microdilution method. MFCs were the lowest drug dilutions that resulted in fewer than three colonies. Voriconazole showed similar or better fungicidal activity (MFC at which 90% of isolates tested are killed [MFC(90)], 1 to 2 microg/ml) than the reference agents for Aspergillus spp. with the exception of Aspergillus terreus (MFC(90) of voriconazole and amphotericin B, >8 microg/ml). The voriconazole geometric mean (G mean) MFC for Scedosporium apiospermum was lower (2.52 microg/ml) than those of the other two agents (5.75 to 7.5 microg/ml). In contrast, amphotericin B and itraconazole G mean MFCs for R. arrhizus were 2.1 to 2.2 microg/ml, but that for voriconazole was >8 microg/ml. Little or no fungicidal activity was shown for Fusarium spp. (2 to >8 microg/ml) and Scedosporium prolificans (>8 microg/ml) by the three agents, but voriconazole had some activity against P. lilacinus and T. longibrachiatum (G mean MFCs, 1.8 and 4 microg/ml, respectively). The fungicidal activity of the three agents was similar (G mean MFC, 1.83 to 2.36 microg/ml) for the dematiaceous fungi with the exception of the azole MFCs (>8 microg/ml) for some Bipolaris spicifera and Dactylaria constricta var. gallopava. These data extend and corroborate the available fungicidal results for the three agents. The role of the MFC as a predictor of clinical outcome needs to be established in clinical trials by following standardized testing conditions for determination of these in vitro values.
Similar articles
-
Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.J Clin Microbiol. 2001 Apr;39(4):1360-7. doi: 10.1128/JCM.39.4.1360-1367.2001. J Clin Microbiol. 2001. PMID: 11283057 Free PMC article.
-
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.Rev Iberoam Micol. 2003 Dec;20(4):121-36. Rev Iberoam Micol. 2003. PMID: 15456349 Review.
-
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.J Antimicrob Chemother. 1998 Dec;42(6):741-5. doi: 10.1093/jac/42.6.741. J Antimicrob Chemother. 1998. PMID: 10052897
-
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.J Clin Microbiol. 2007 Jun;45(6):1811-20. doi: 10.1128/JCM.00134-07. Epub 2007 Apr 11. J Clin Microbiol. 2007. PMID: 17428932 Free PMC article.
-
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature.Mycopathologia. 2001;150(3):101-15. doi: 10.1023/a:1010954803886. Mycopathologia. 2001. PMID: 11469757 Review.
Cited by
-
Molecular mycological diagnosis and correct antimycotic treatments.J Clin Microbiol. 2005 Jul;43(7):3584; author reply 3584-5. doi: 10.1128/JCM.43.7.3584-3585.2005. J Clin Microbiol. 2005. PMID: 16000516 Free PMC article. No abstract available.
-
Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.Mycopathologia. 2011 Feb;171(2):111-7. doi: 10.1007/s11046-010-9358-6. Epub 2010 Aug 29. Mycopathologia. 2011. PMID: 20803255
-
Diversity of Bipolaris species in clinical samples in the United States and their antifungal susceptibility profiles.J Clin Microbiol. 2012 Dec;50(12):4061-6. doi: 10.1128/JCM.01965-12. Epub 2012 Oct 10. J Clin Microbiol. 2012. PMID: 23052310 Free PMC article.
-
Ochroconis calidifluminalis, a sibling of the neurotropic pathogen O. gallopava, isolated from hot spring.Mycopathologia. 2010 Jul;170(1):21-30. doi: 10.1007/s11046-010-9292-7. Epub 2010 Mar 7. Mycopathologia. 2010. PMID: 20213501
-
Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.Antimicrob Agents Chemother. 2004 May;48(5):1778-87. doi: 10.1128/AAC.48.5.1778-1787.2004. Antimicrob Agents Chemother. 2004. PMID: 15105135 Free PMC article.
References
-
- Anaissie E, Kantarjian H, Ro H, Hopfer R, Rolston R K, Fainstein V, Bodey G. The emerging role of Fusarium infections in patients with cancer. Medicine. 1988;67:77–83. - PubMed
-
- Berenguer J, Rodriguez-Tudela J L, Richard C, Alvarez M, Sanz M A, Guztelurrutia L the Scedosporium prolificans Spanish Study Group. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Medicine. 1997;76:256–265. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous